Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SPD Swiss Precision Diagnostics (SPD) is a global leader in the consumer diagnostics industry, primarily recognized for its flagship brand Clearblue. Established in 2007 as a joint venture between Procter & Gamble and Alere (now part of Abbott), the company focuses on the research, design, and manufacture of advanced home diagnostic tests. SPD's primary R&D facility, SPD Development Company Ltd, is located in Bedford, UK, and is responsible for pioneering digital pregnancy tests and sophisticated fertility monitoring systems. The company's products utilize high-sensitivity lateral flow technology and digital sensors to provide accurate results for women's health monitoring. SPD continues to innovate in the field of rapid diagnostics, recently expanding its portfolio into menopause staging and connected health solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Strategic Product Development.